𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A French approach to cost-effectiveness analysis?

✍ Scribed by Gérard de Pouvourville


Book ID
106295250
Publisher
Springer
Year
2010
Tongue
French
Weight
104 KB
Volume
11
Category
Article
ISSN
1618-7598

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


An opportunity cost approach to sample s
✍ A. Gafni; S. D. Walter; S. Birch; P. Sendi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract The inclusion of economic evaluations as part of clinical trials has led to concerns about the adequacy of trial sample size to support such analysis. The analytical tool of cost‐effectiveness analysis is the incremental cost‐effectiveness ratio (ICER), which is compared with a threshol

Surrogates, meta-analysis and cost-effec
✍ Neil Hawkins; Gerry Richardson; Alex J Sutton; Nicola J Cooper; Chris Griffiths; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## SUMMARY Estimates of cost‐effectiveness analyses are typically obtained either directly from ‘trial’ based analyses or indirectly via surrogate endpoints in ‘model’ based analyses. Data from clinical trials that include both surrogate and final endpoints can be used in a joint analysis that comb

Bayesian cost-effectiveness analysis wit
✍ Miguel A. Negrín; Francisco J. Vázquez-Polo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB 👁 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d